Mirum Pharmaceuticals, Inc. (MIRM)
95.48
+1.90
(+2.02%)
USD |
NASDAQ |
Jun 09, 16:00
95.52
+0.04
(+0.04%)
After-Hours: 20:00
Mirum Pharmaceuticals Research and Development Expense (Quarterly) : 97.84M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 178.80M |
| Incyte Corp. | 515.90M |
| Ionis Pharmaceuticals, Inc. | 210.17M |
| Travere Therapeutics, Inc. | 57.09M |
| Vertex Pharmaceuticals, Inc. | 961.60M |